Resources with keywords: Monkeypox
Delaney KP, Sanchez T, Hannah M, et al.
The FDA is informing health care providers of the potential risk of transmission of monkeypox virus through fecal microbiota for transplantation (FMT) products– additional safety protections are needed.
The interview discusses modes transmission, communication, and vaccination.
Delaney KP, Sanchez T, Hannah M, et al.
MacNeill AL
This review provides a brief history of the impacts that a human-specific Orthopoxvirus (OPXV), Variola virus, had on mankind, recalls how critical vaccination was for the eradication of this disease, and discusses the consequences of discontinuing vaccination against OPXV.
This document includes Monkeypox in the EXAMPLE OF CATEGORY A: UN2814, INFECTIOUS SUBSTANCES AFFECTING HUMANS
Members of the APHL Biosafety and Biosecurity Committee developed this fact sheet to assist laboratorians with safely testing potential monkeypox samples.
JYNNEOS is the only FDA-licensed vaccine in the United States to prevent monkeypox disease in individuals 18 years of age and older.
